85
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with the Change in Carotid Maximum Intima-Media Thickness in Patients with Moderate-to-Advanced Stage Chronic Kidney Disease

ORCID Icon, , , , , , ORCID Icon, , , , , , , & show all
Pages 3637-3643 | Published online: 12 Oct 2020

References

  • Bello AK, Alrukhaimi M, Ashuntantang GE, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl (2011). 2017;7(2):122–129. doi:10.1016/j.kisu.2017.07.007
  • Valdivielso JM, Rodriguez-Puyol D, Pascual J, et al. Atherosclerosis in chronic kidney disease: more, less, or just different? Arterioscler Thromb Vasc Biol. 2019;39(10):1938–1966. doi:10.1161/ATVBAHA.119.312705
  • Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, et al. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–352. doi:10.1016/S0140-6736(13)60595-4
  • Ahmadi A, Argulian E, Leipsic J, Newby DE, Narula J. From subclinical atherosclerosis to plaque progression and acute coronary events: JACC state-of-the-art review. J Am Coll Cardiol. 2019;74(12):1608–1617. doi:10.1016/j.jacc.2019.08.012
  • O’Leary DH, Bots ML. Imaging of atherosclerosis: carotid intima-media thickness. Eur Heart J. 2010;31(14):1682–1689. doi:10.1093/eurheartj/ehq185
  • Irie Y, Katakami N, Kaneto H, et al. Maximum carotid intima-media thickness improves the prediction ability of coronary artery stenosis in type 2 diabetic patients without history of coronary artery disease. Atherosclerosis. 2012;221(2):438–444. doi:10.1016/j.atherosclerosis.2012.01.022
  • Hirano M, Nakamura T, Kitta Y, et al. Short-term progression of maximum intima-media thickness of carotid plaque is associated with future coronary events in patients with coronary artery disease. Atherosclerosis. 2011;215(2):507–512. doi:10.1016/j.atherosclerosis.2011.01.014
  • Kokubo Y, Watanabe M, Higashiyama A, Nakao YM, Nakamura F, Miyamoto Y. Impact of intima-media thickness progression in the common carotid arteries on the risk of incident cardiovascular disease in the suita study. J Am Heart Assoc. 2018;7(11):11. doi:10.1161/JAHA.117.007720
  • Kendrick J, Chonchol M, Gnahn H, Sander D. Higher systolic blood pressure is associated with progression of carotid intima-media thickness in patients with chronic kidney disease. Kidney Int. 2010;77(9):794–800. doi:10.1038/ki.2009.557
  • Desbien AM, Chonchol M, Gnahn H, Sander D. Kidney function and progression of carotid intima-media thickness in a community study. Am J Kidney Dis. 2008;51(4):584–593. doi:10.1053/j.ajkd.2007.11.026
  • Matsuo S, Imai E, Horio M, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53(6):982–992. doi:10.1053/j.ajkd.2008.12.034
  • Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74(6):1399–1406. doi:10.1161/01.CIR.74.6.1399
  • Qu B, Qu T. Causes of changes in carotid intima-media thickness: a literature review. Cardiovasc Ultrasound. 2015;13(1):46. doi:10.1186/s12947-015-0041-4
  • Rosvall M, Persson M, Ostling G, et al. Risk factors for the progression of carotid intima-media thickness over a 16-year follow-up period: the malmo diet and cancer study. Atherosclerosis. 2015;239(2):615–621. doi:10.1016/j.atherosclerosis.2015.01.030
  • Toprak A, Kandavar R, Toprak D, et al. C-reactive protein is an independent predictor for carotid artery intima-media thickness progression in asymptomatic younger adults (from the Bogalusa Heart Study). BMC Cardiovasc Disord. 2011;11(1):78. doi:10.1186/1471-2261-11-78
  • Ross R. Atherosclerosis–an inflammatory disease. N Engl J Med. 1999;340(2):115–126.
  • Mikolasevic I, Zutelija M, Mavrinac V, Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis. 2017;10:35–45. doi:10.2147/IJNRD.S101808
  • Kobayashi S, Maesato K, Moriya H, Ohtake T, Ikeda T. Insulin resistance in patients with chronic kidney disease. Am J Kidney Dis. 2005;45(2):275–280. doi:10.1053/j.ajkd.2004.09.034
  • Ai M, Tanaka A, Ogita K, et al. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrinol Metab. 2000;85(10):3557–3560. doi:10.1210/jcem.85.10.6894
  • Vaziri ND, Liang K. Down-regulation of VLDL receptor expression in chronic experimental renal failure. Kidney Int. 1997;51(3):913–919.
  • Rigatto C, Levin A, House AA, Barrett B, Carlisle E, Fine A. Atheroma progression in chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):291–298. doi:10.2215/CJN.01840408